Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
March 09 2017 - 2:37PM
Edgar (US Regulatory)
|
|
UNITED STATES
|
|
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
|
|
Washington, D.C. 20549
|
|
|
|
|
|
|
|
FORM 15
|
|
|
|
|
|
|
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12 (g)
|
|
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
FILE
|
|
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES ACT OF
1934.
|
|
|
Commission File
Number
|
0-23015
|
|
|
|
|
HH Biotechnology Holdings Company
|
|
|
|
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
C
Site 25-26F Presidential Bldg.,
No.
69 Heping North Street,
Heping
District, Shenyang 110003, PRC
|
|
|
|
0086-24-22813888
|
|
|
|
(Address,
including zip code, and telephone number, including
|
|
|
|
area
code, of registrant’s principal executive
offices)
|
|
|
|
Common Stock, par value $0.001 per share (“Common
Stock”)
|
|
|
|
(Title
of each class of securities covered by this Form)
|
|
|
|
|
|
None
|
|
|
|
(Title
of all other classes of securities for which a duty to file
reports
|
|
|
|
under
section 13(a) or 15(d) remains)
|
|
|
|
|
Please
place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file
reports:
|
|
|
|
|
Rule
12g-4(a)(1)
|
X
|
|
|
|
Rule
12g-4(a)(2)
|
|
|
|
|
Rule
12h-3(b)(1)(i)
|
|
|
|
|
Rule
12h-3(b)(1)(ii)
|
|
|
|
|
Rule
15d-6
|
|
|
|
|
Rule
15d-22(b)
|
|
|
|
|
|
Approximate number
of holders of record as of the certification or notice date:
151
|
|
Pursuant to the
requirements of the Securities Exchange Act of 1934, Caspian
Services, Inc. has caused this
|
|
certification/notice
to be signed on its behalf by the undersigned duly authorized
person
|
|
|
|
|
|
Date:
|
February 15, 2017
|
|
By:
|
/s/
Sheng Jiang
|
|
|
Sheng
Jiang
|
|
|
Chief
Executive Officer
|
Instruction: This
form is required by Rules 12g-4, 12h-3 and 15d-6 of the General
Rules and Regulations under the Securities Exchange Act of 1934.
The registrant shall file with the Commission three copies of Form
15, one of which shall be manually signed. It may be signed by an
officer of the registrant, by counsel or by any other duly
authorized person. The name and title of the person signing the
form shall be typed or printed under the signature.
HH Biotechnology (CE) (USOTC:HHBT)
Historical Stock Chart
From Nov 2024 to Dec 2024
HH Biotechnology (CE) (USOTC:HHBT)
Historical Stock Chart
From Dec 2023 to Dec 2024
